1 completed, 1 recruiting, 1 terminated. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
Follow CliniMACS® CD34 Reagent System: new trials by email Literature Review of CliniMACS® CD34 Reagent System trials Research Report on CliniMACS® CD34 Reagent System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant CliniMacs® - Graft Vs Host Disease, Graft-versus-host-disease | Not applicable | Recruiting | Christopher Dvorak | 90 | 2019-12-19 | 2026-04-13 |
| Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies CliniMACS® CD34 Reagent System, Fludarabine, Melphalan - Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 2 | Terminated | Weill Medical College of Cornell University | 2 | 2012-10-26 | 2018-07-11 |
| Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation CliniMACS® CD34 Reagent System, Fludarabine, Melphalan - Hematologic Malignancies | Phase 2 | Completed | Weill Medical College of Cornell University | 270 | 2012-10-16 | 2026-08-19 |
Lymphoma (2) · Graft vs Host Disease (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Neoplasms, Plasma Cell (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Weill Medical College of Cornell University (2) · Christopher Dvorak (1)
United States (3)
Alexandra Gomez Arteaga, MD (1) · Christopher C Dvorak, MD (1) · Koen van Besien, MD, PhD (1)